一、基本信息

侯思聪，女，博士，副教授，硕士生导师，扬州大学附属医院消化内科主治医师，现承担消化科临床、科研和教学工作。

二、研究方向

主要从事消化道肿瘤及炎症性肠病的基础及临床研究。

三、承担项目

1、国家自然科学基金面上项目，82372959，2024-01至2027-12，在研，主持。

2、江苏省卫健委面上项目，H2023035，2024-01至2026-12，在研，主持。

3、江苏省自然科学基金面上项目，BK20221373，2022-07至2025-06，在研，主持。

4、国家自然科学基金青年科学基金项目，31800675，2019-01至2021-12，结题，主持。

四、代表性论著

1.X.Hu,J.Li,Y.Sun,D.Wu,T.Zhao,M.Ma,J.Chen,M.Wang,S.Hou, Combined use of CDAI and blood indices for assessing endoscopic activity in ileocolic Crohn's disease, BMC gastroenterology, 2023, 23(1), 337.

2.S. Hou, X. Hao, J. Li,S.Weng,J.Wang,T.Zhao,WLi,X.Hu,B.Deng,J.Gu,Q.Hang, TM4SF1 promotes esophageal squamous cell carcinoma metastasis by interacting with integrin α6. Cell death & disease, 2022, 13(7), 609.

3.J. Li,Y. Sun, X. Hu, T. Zhao, G, Yao, W. Xiao, Y. Ding,S. Hou, M. Wang, Impact of the SARS-COV-2 Delta variant on the psychological states and health-related quality of life in patients with Crohn's disease, Front Med (2022).

4.S. Hou, Z. Pan, X. Hao, Q. Hang, Y. Ding, Recent Progress in the Neoadjuvant Treatment Strategy for Locally Advanced Esophageal Cancer, Cancers (Basel) 13(20) (2021).

5.S. Hou, Q. Hang, T. Isaji, T. Fukuda, J. Gu, Identification of the minimal N-glycosylation on integrin alpha5beta1 required for its inhibitory effect on EGFR signaling and cell proliferation, Biochem Biophys Res Commun 523(1) (2020) 226-232.

6.S. Hou, W. Jin, W. Xiao, B. Deng, D. Wu, J. Zhi, K. Wu, X. Cao, S. Chen, Y. Ding, H. Shi, Integrin alpha5 promotes migration and cisplatin resistance in esophageal squamous cell carcinoma cells, Am J Cancer Res 9(12) (2019) 2774-2788.

7.S. Hou, Q. Hang, T. Isaji, J. Lu, T. Fukuda, J. Gu, Importance of membrane proximal N-glycosylation on integrin beta1 in its activation and complex formation, FASEB J 30(12) (2016) 4120-4131.